Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Gynecologic Oncology|January 23, 2025
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study resultsDavid M O'Malley, Giovani M Bariani, Philippe A Cassier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 StudyDavid M O'Malley, Giovanni Mendonca Bariani, Philippe A Cassier, et al.Blood|December 12, 2013
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodiesHolbrook E Kohrt, Ariane Thielens, Aurelien Marabelle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2023
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on ImmunotherapyYounes Belkouchi, Hugues Talbot, Nathalie Lassau, et al.Journal for Immunotherapy of Cancer|September 7, 2023
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancerPierre Decazes, Samy Ammari, Younes Belkouchi, et al.Journal for Immunotherapy of Cancer|November 29, 2024
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancerFilippo G Dall'Olio, Wael Salem Zrafi, Quentin Blampey, et al.Nature Reviews. Clinical Oncology|May 5, 2016
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combinationCeline Boutros, Ahmad Tarhini, Emilie Routier, et al.Journal for Immunotherapy of Cancer|June 23, 2026
VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLCMatthieu Roulleaux-Dugage, Andrey Yurchenko, Sergey Nikolaev, et al.European Journal of Cancer (Oxford, England : 1990)|August 7, 2020
Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancerPatricia Martin-Romano, Samy Ammari, Yolla El-Dakdoukti, et al.Nature Cancer|February 20, 2025
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trialAurelien Marabelle, David M O'Malley, Andrew E Hendifar, et al.Pageof 7